Iryna Kuchuk

1.6k total citations
43 papers, 1.2k citations indexed

About

Iryna Kuchuk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Iryna Kuchuk has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Iryna Kuchuk's work include Bone health and treatments (19 papers), Cancer Diagnosis and Treatment (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Iryna Kuchuk is often cited by papers focused on Bone health and treatments (19 papers), Cancer Diagnosis and Treatment (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Iryna Kuchuk collaborates with scholars based in Canada, Israel and United States. Iryna Kuchuk's co-authors include Mark Clemons, Christina Addison, Brian Hutton, Sasha Mazzarello, Paul Wheatley‐Price, Michal J. Besser, Sara Apter, Avraham J. Treves, Gal Markel and Jacob Schachter and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Iryna Kuchuk

41 papers receiving 1.2k citations

Peers

Iryna Kuchuk
Timothy Clay Australia
Michael Method United States
Gwyn Bebb Canada
David L. Bajor United States
Juergen Wolf Germany
Tamer M. Fouad United States
S. David Nathanson United States
Jeff Lin United States
Roxanne Payne United States
Timothy Clay Australia
Iryna Kuchuk
Citations per year, relative to Iryna Kuchuk Iryna Kuchuk (= 1×) peers Timothy Clay

Countries citing papers authored by Iryna Kuchuk

Since Specialization
Citations

This map shows the geographic impact of Iryna Kuchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iryna Kuchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iryna Kuchuk more than expected).

Fields of papers citing papers by Iryna Kuchuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iryna Kuchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iryna Kuchuk. The network helps show where Iryna Kuchuk may publish in the future.

Co-authorship network of co-authors of Iryna Kuchuk

This figure shows the co-authorship network connecting the top 25 collaborators of Iryna Kuchuk. A scholar is included among the top collaborators of Iryna Kuchuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iryna Kuchuk. Iryna Kuchuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuchuk, Iryna, et al.. (2024). The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 205(2). 241–248. 1 indexed citations
2.
Leviov, Michelle, Iryna Kuchuk, Shani Paluch–Shimon, et al.. (2023). Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study. npj Breast Cancer. 9(1). 49–49.
3.
Leviov, Michelle, Iryna Kuchuk, Shani Paluch–Shimon, et al.. (2022). 149P Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data. Annals of Oncology. 33. S607–S608. 1 indexed citations
4.
Kuchuk, Iryna, Tzippy Shochat, Aarón Sulkes, et al.. (2021). Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study. Breast Cancer Research and Treatment. 188(2). 379–387. 2 indexed citations
5.
6.
Arnaout, Angel, Iryna Kuchuk, Nathaniel Bouganim, et al.. (2016). Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study. Current Oncology. 23(3). 276–279. 10 indexed citations
8.
9.
Addison, Christina, Nathaniel Bouganim, John Hilton, et al.. (2014). A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. Breast Cancer Research and Treatment. 144(3). 615–624. 21 indexed citations
10.
Kuchuk, Iryna, Jennifer L. Beaumont, Mark Clemons, et al.. (2013). Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers. Journal of bone oncology. 2(4). 154–157. 14 indexed citations
11.
Kuchuk, Iryna, Nathaniel Bouganim, Lisa Vandermeer, et al.. (2013). Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Research and Treatment. 142(1). 101–107. 71 indexed citations
12.
Kuchuk, Iryna, Brian Hutton, Patrícia Moretto, et al.. (2013). Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre. Journal of bone oncology. 2(4). 137–144. 87 indexed citations
13.
Hutton, Brian, Urban Emmenegger, Sasha Mazzarello, et al.. (2013). Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey. Journal of bone oncology. 2(3). 105–109. 15 indexed citations
14.
Fralick, Michael, Nathaniel Bouganim, Richard Kremer, et al.. (2012). Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results. Journal of bone oncology. 1(3). 69–73. 8 indexed citations
15.
Kuchuk, Iryna, Mark Clemons, & Christina Addison. (2012). Time to Put an End to the “One Size Fits All” Approach to Bisphosphonate Use in Patients with Metastatic Breast Cancer?. Current Oncology. 19(5). 303–304. 21 indexed citations
16.
Kuchuk, Iryna, et al.. (2012). Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists. Journal of bone oncology. 2(1). 38–46. 16 indexed citations
17.
Kuchuk, Iryna, Demetrios Simos, Christina Addison, & Mark Clemons. (2012). A national portfolio of bone oncology trials—The Canadian experience in 2012. Journal of bone oncology. 1(3). 95–100. 12 indexed citations
18.
Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2010). Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients. Clinical Cancer Research. 16(9). 2646–2655. 352 indexed citations
19.
Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2009). Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients. Journal of Immunotherapy. 32(4). 415–423. 97 indexed citations
20.
Shinar, Yael, et al.. (2007). Unique spectrum of MEFV mutations in Iranian Jewish FMF patients clinical and demographic significance. Lara D. Veeken. 46(11). 1718–1722. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026